Levobupivacaina Bioindustria L.I.M

Levobupivacaine, the active ingredient in Levobupivacaina Bioindustria L.I.M, is a local anesthetic presented as a sterile solution for epidural use. It provides regional nerve block for surgical procedures and pain management in adult patients. It is indicated for epidural anesthesia in obstetric, orthopedic and abdominal surgeries, offering prolonged sensory blockade with reduced motor impairment.

GNH USA supplies Levobupivacaina Bioindustria L.I.M as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Levobupivacaine is employed in epidural anesthesia to achieve regional nerve block for various surgical and obstetric procedures. - Epidural anesthesia: provides surgical anesthesia and analgesia during labor, cesarean sections, and lower abdominal surgeries. - Peripheral nerve block: delivers targeted anesthesia for orthopedic limb surgeries and postoperative pain control. - Postoperative analgesia: extends pain relief after major surgeries, reducing the need for systemic opioids.

Levobupivacaine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Hypotension: decreased blood pressure due to sympathetic blockade. - Bradycardia: slowed heart rate, especially with high spinal spread. - Nausea and vomiting: gastrointestinal discomfort following administration. - Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects: - Central nervous system toxicity: seizures or loss of consciousness. - Cardiac arrhythmias: ventricular tachycardia or cardiac arrest. - Allergic reactions: urticaria, bronchospasm, or anaphylaxis.

When using levobupivacaine, clinicians should observe several safety precautions to minimize risks. - Cardiac assessment: evaluate patients with known heart disease before administration. - Avoid intravascular injection: aspirate before injection to prevent systemic toxicity. - Hepatic impairment: use reduced doses in patients with severe liver dysfunction. - Obstetric use: monitor fetal heart rate when administered during labor. - Drug compatibility: do not mix with other local anesthetics unless compatibility is confirmed. - Store below 25°C: keep in the original container, protect from moisture and light.

Levobupivacaine can interact with other medications, affecting its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine): increase risk of cardiac toxicity. - Beta‑blockers: may exacerbate bradycardia and hypotension. - Other local anesthetics: additive neuro‑ and cardiotoxic effects.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma concentrations. - General anesthetics (e.g., propofol): enhance central nervous system depression. - Hypotensive agents (e.g., clonidine): increase likelihood of profound hypotension.